Who are we?
9D Arrays is a medical technology startup, supporting medical and healthcare innovations. Our company was founded based on a medical research project.
What is cancer?
Cancer is a disease that abnormal cells develop out of control and spread to other parts of the body. These cells can affect one health, probably leading to death.
What is cancer recurrence?
Cancer recurrence means cancer coming back after treatment. It is difficult to predict whether and when cancer recurs, so 9D Arrays has a mission to improve cancer patient health.
How can we take care of patient health?
9D Arrays built the apps to detect oral cancer and predict recurrence. We provide our clients with a high-quality service that is reliable and able to be trusted for use on patients.
Why develop prediction tools for oral cancer?
According to World Health Organization, more than 389 thousand people were diagnosed with oral cancer globally, and the number of death was about 188 thousand. The recurrence rate of oral cancer can vary between 20% and 86% in the first year after treatments.
How do we help oral cancer patients?
Our apps are launched on cloud to serve everyone globally. Medical professionals can use LNTD to detect oral cancer in histopathology images. For prognosis, MILP was developed based on biomarkers to discriminate the patients with early recurrence from late/no recurrence.
References
- Website citation:
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [DD Month YYYY]. - Cancer incidence and mortality data:
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338. - Cancer recurrence data:
Blatt, S., Krüger, M., Sagheb, K., Barth, M., Kämmerer, P. W., Al-Nawas, B., & Sagheb, K. (2022). Tumor recurrence and follow-up intervals in oral squamous cell carcinoma. Journal of Clinical Medicine, 11(23), 7061. Sasaki M., Aoki T., Karakida K., Otsuru M., Takahashi M., Akamatsu T., Sakamoto H., Ota Y. Postoperative follow-up strategy in patients with oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 2011;69:e105–e111. doi: 10.1016/j.joms.2010.11.039.